Potential Impact of Nirsevimab on RSV Transmission and Medically Attended Lower Respiratory Tract Illness Caused by RSV: A Disease Transmission Model.

Voirin, Nicolas; Virlogeux, Victor; Demont, Clarisse; Kieffer, Alexia

Voirin, Nicolas; Virlogeux, Victor; Demont, Clarisse; Kieffer, Alexia.

Afiliação

Voirin N; Epidemiology and Modelling in Infectious Diseases (EPIMOD), Lent, France.
Virlogeux V; Epidemiology and Modelling in Infectious Diseases (EPIMOD), Lent, France.
Demont C; Hospices Civils de Lyon, Lyon, France.
Kieffer A; Vaccine and Epidemiology Modelling, Sanofi Pasteur, Lyon, France.

Infect Dis Ther ; 11(1): 277-292, 2022 Feb.

Article em En | MEDLINE | ID: mdl-34813073

Palavras-chave

Disease transmission model; Immunization/prophylaxis strategy; Medically attended lower respiratory tract illness; Nirsevimab; RSV

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Infect Dis Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google